Overview
Drug Development During and After COVID19
Drug development has always been challenging, but the COVID-19 pandemic has changed the game. Programs at all stages have been affected, but what is the lasting impact? What must we do now to keep moving forward, and how do we pave the way for future success?
Join our scientists and colleagues for an intimate networking and discussion event. Together, we’ll explore how COVID-19 continues to shape the evolution of the research ecosystem and share strategies to maintain progress in a time of crisis.
After our group discussion, connect with peers in our breakout rooms, where you network and can chat about topics like future expectations and guidance for your programs.
We might not be able to gather in person, but you can still enjoy Charles River hospitality. Each of our guests will receive a voucher for Snack Magic to customize a box of treats delivered in time for the event.
Your Hosts:
Jos Mertens, PhD, DABT
Senior Principal Scientific Advisor
Michael V. Templin, PhD, DABT
Director, Scientific Advisory Services
Sam Chuang, PhD
Scientific Advisor
Mary Parker
Senior Science Writer
Get more information on our participation at the 2021 Society of Toxicology (SOT) Annual Meeting and ToxExpo